144 related articles for article (PubMed ID: 30846229)
1. Biclonal presentation of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia.
Wang W; Ding Y; Campbell A; Handy BC; Medeiros LJ; Lin P
Pathology; 2019 Apr; 51(3):340-343. PubMed ID: 30846229
[No Abstract] [Full Text] [Related]
2. [The pathology and genetic background of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia].
Timár B
Magy Onkol; 2017 Mar; 61(1):6-11. PubMed ID: 28273183
[TBL] [Abstract][Full Text] [Related]
3. Improved accuracy of discrimination between IgM multiple myeloma and Waldenström macroglobulinaemia by testing for MYD88 L265P mutations.
Willenbacher W; Willenbacher E; Brunner A; Manzl C
Br J Haematol; 2013 Jun; 161(6):902-4. PubMed ID: 23560587
[No Abstract] [Full Text] [Related]
4. Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Correa JG; Cibeira MT; Tovar N; Isola I; Pedrosa F; Díaz T; Lozano E; Magnano L; Rosiñol L; Bladé J; Fernández de Larrea C
Br J Haematol; 2017 Dec; 179(5):849-851. PubMed ID: 27605200
[No Abstract] [Full Text] [Related]
5. To select or not to select? The role of B-cell selection in determining the MYD88 mutation status in Waldenström Macroglobulinaemia.
Gustine J; Meid K; Xu L; Hunter ZR; Castillo JJ; Treon SP
Br J Haematol; 2017 Mar; 176(5):822-824. PubMed ID: 26936399
[No Abstract] [Full Text] [Related]
6. Waldenström macroglobulinaemia: the key questions.
D'Souza A; Ansell S; Reeder C; Gertz MA
Br J Haematol; 2013 Aug; 162(3):295-303. PubMed ID: 23651417
[TBL] [Abstract][Full Text] [Related]
7. Uncommon lymphoplasmacytic lymphoma with IgA paraproteinemia: a challenging clinical diagnosis solved by MYD88 mutation analysis.
Martino G; Marra A; Ascani S; Sportoletti P
Ann Hematol; 2019 Jun; 98(6):1507-1508. PubMed ID: 30426157
[No Abstract] [Full Text] [Related]
8. Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Chakraborty R; Kapoor P; Ansell SM; Gertz MA
Expert Rev Anticancer Ther; 2015; 15(10):1143-56. PubMed ID: 26196236
[TBL] [Abstract][Full Text] [Related]
9. MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia.
Gustine JN; Meid K; Hunter ZR; Xu L; Treon SP; Castillo JJ
Br J Haematol; 2018 Feb; 180(4):578-581. PubMed ID: 27748515
[No Abstract] [Full Text] [Related]
10. Genetic analysis of Diffuse Large B-cell Lymphoma occurring in cases with antecedent Waldenström Macroglobulinaemia reveals different patterns of clonal evolution.
Talaulikar D; Biscoe A; Lim JH; Gibson J; Arthur C; Mackinlay N; Saxena K; Cheng YY; Chen VM
Br J Haematol; 2019 May; 185(4):767-770. PubMed ID: 30338525
[No Abstract] [Full Text] [Related]
11. MYD88L265P mutated IgA lymphoplasmacytic lymphoma.
Urquieta Lam M; Moreno Aguirre A; Pereña Gonzalez A; Gonzalez de Villambrosia S; Nuñez Cespedes J; García Reyero J; Montes Moreno S
Histopathology; 2019 Oct; 75(4):608-612. PubMed ID: 31107988
[No Abstract] [Full Text] [Related]
12. [Waldenström macroglobulinaemia].
Tomowiak C; Poulain S; Debiais C; Guidez S; Leleu X
Presse Med; 2019; 48(7-8 Pt 1):832-841. PubMed ID: 31444019
[TBL] [Abstract][Full Text] [Related]
13. MALT lymphoma with IgM paraprotein and bone marrow involvement mimicking Waldenström macroglobulinaemia.
Wang SC; Huang WT; Ma MC; Medeiros LJ; Chang KC
Pathology; 2019 Aug; 51(5):549-553. PubMed ID: 31202483
[No Abstract] [Full Text] [Related]
14. Significances of MYD88
Meng Q; Cao XX; Li J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):578-582. PubMed ID: 28877839
[TBL] [Abstract][Full Text] [Related]
15. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM; Castillo JJ
Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
[TBL] [Abstract][Full Text] [Related]
16. [Successful diagnosis of lymphoplasmacytic lymphoma with IgG paraprotein using MYD88 L265P mutation analysis].
Abe M; Saburi M; Itani K; Kohno K; Soga Y; Kondo Y; Kawano Y; Nakayama T
Rinsho Ketsueki; 2018; 59(6):695-697. PubMed ID: 29973445
[TBL] [Abstract][Full Text] [Related]
17. Lymphoplasmacytic Lymphoma Presenting with Diarrhea and Joint Pain Which was Successfully Diagnosed by an MYD88 Mutation Analysis.
Fukushima M; Okoshi Y; Fukazawa K; Koshino M; Ishiguro S; Mitsuhashi S; Saitoh H; Iijima T; Kojima H; Hori M
Intern Med; 2017; 56(7):847-851. PubMed ID: 28381754
[TBL] [Abstract][Full Text] [Related]
18. MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival.
Treon SP; Gustine J; Xu L; Manning RJ; Tsakmaklis N; Demos M; Meid K; Guerrera ML; Munshi M; Chan G; Chen J; Kofides A; Patterson CJ; Yang G; Liu X; Severns P; Dubeau T; Hunter ZR; Castillo JJ
Br J Haematol; 2018 Feb; 180(3):374-380. PubMed ID: 29181840
[TBL] [Abstract][Full Text] [Related]
19. Watch and wait in Waldenström macroglobulinaemia: looking for who to watch carefully and who can wait without worrying. Is it that simple?
Durot E; Delmer A
Br J Haematol; 2021 Oct; 195(2):155-157. PubMed ID: 34472092
[No Abstract] [Full Text] [Related]
20. Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
Manasanch EE; Braylan R; Stetler-Stevenson M; Yuan C; Gounden V; Korde N; Tageja N; Bhutani M; Calvo K; Maric I; Roschewski M; Staudt LM; Landgren O
Leuk Lymphoma; 2014 Jun; 55(6):1402-3. PubMed ID: 23915224
[No Abstract] [Full Text] [Related]
[Next] [New Search]